Back to Search Start Over

ViroPharma/Wyeth's HCV-086 enters clinic

Source :
Pharma Marketletter. March 1, 2004
Publication Year :
2004

Abstract

US firms ViroPharma and Wyeth have initiated a Phase I clinical program for HCV-086, an antiviral agent with potential use in the treatment of hepatitis C. The companies will initially [...]

Details

Language :
English
ISSN :
13558501
Database :
Gale General OneFile
Journal :
Pharma Marketletter
Publication Type :
News
Accession number :
edsgcl.113704634